Charles Schwab’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-225,060
| Closed | -$71.2M | – | 3541 |
|
|
2023
Q4 | $71.2M | Buy |
225,060
+6,721
| +3% | +$2.13M | 0.02% | 738 |
|
|
2023
Q3 | $36.9M | Buy |
218,339
+32,548
| +18% | +$5.5M | 0.01% | 1099 |
|
|
2023
Q2 | $40.3M | Sell |
185,791
-65,297
| -26% | -$14.2M | 0.01% | 1006 |
|
|
2023
Q1 | $45.6M | Buy |
251,088
+20,021
| +9% | +$3.64M | 0.01% | 904 |
|
|
2022
Q4 | $45.4M | Buy |
231,067
+13,552
| +6% | +$2.66M | 0.01% | 886 |
|
|
2022
Q3 | $48.9M | Buy |
217,515
+46,168
| +27% | +$10.4M | 0.02% | 773 |
|
|
2022
Q2 | $21.7M | Buy |
171,347
+10,956
| +7% | +$1.39M | 0.01% | 1348 |
|
|
2022
Q1 | $20.3M | Buy |
160,391
+4,332
| +3% | +$549K | 0.01% | 1537 |
|
|
2021
Q4 | $20.4M | Buy |
156,059
+3,186
| +2% | +$417K | 0.01% | 1557 |
|
|
2021
Q3 | $18.7M | Buy |
152,873
+15,657
| +11% | +$1.92M | 0.01% | 1645 |
|
|
2021
Q2 | $15.6M | Buy |
137,216
+16,359
| +14% | +$1.86M | 0.01% | 1750 |
|
|
2021
Q1 | $14.5M | Buy |
120,857
+13,685
| +13% | +$1.65M | 0.01% | 1742 |
|
|
2020
Q4 | $10.9M | Buy |
107,172
+1,719
| +2% | +$175K | ﹤0.01% | 1818 |
|
|
2020
Q3 | $8.15M | Buy |
105,453
+25,090
| +31% | +$1.94M | ﹤0.01% | 1822 |
|
|
2020
Q2 | $8.96M | Buy |
80,363
+14,957
| +23% | +$1.67M | ﹤0.01% | 1716 |
|
|
2020
Q1 | $4.71M | Buy |
65,406
+21,822
| +50% | +$1.57M | ﹤0.01% | 1867 |
|
|
2019
Q4 | $3.28M | Buy |
43,584
+11,329
| +35% | +$854K | ﹤0.01% | 2231 |
|
|
2019
Q3 | $527K | Buy |
+32,255
| New | +$527K | ﹤0.01% | 2780 |
|